Industry / India
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Wockhardt To Push Insulin On Developed Markets
February 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
Indian drugmaker Wockhardt is preparing for a 'deep dive' into developed markets. The company is focusing on the lucrative insulin sector and will leverage an early mover advantage to maximise returns. BMI notes with interest that this strategy is similar to that recently announced by Israeli firm Teva Pharmaceuticals. Accordingly, given the pre-eminence of the two players, we expect other drugmakers to follow suit.